Alexandria Real Estate Equities Inc
NYSE:ARE
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
44.97
99.5663
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
ARE
stock under the Base Case scenario is
68.33
USD.
Compared to the current market price of 48.76 USD,
Alexandria Real Estate Equities Inc
is
Undervalued by 29%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Alexandria Real Estate Equities Inc.
| US |
|
Boston Properties Inc
NYSE:BXP
|
|
| JP |
|
Nippon Building Fund Inc
TSE:8951
|
|
| FR |
|
Covivio SA
PAR:COV
|
|
| US |
|
Vornado Realty Trust
NYSE:VNO
|
|
| US |
|
COPT Defense Properties
NYSE:CDP
|
|
| JP |
|
Japan Real Estate Investment Corp
TSE:8952
|
|
| AU |
|
Dexus
ASX:DXS
|
|
| JP |
|
Kenedix Office Investment Corp
TSE:8972
|
|
| US |
|
Kilroy Realty Corp
NYSE:KRC
|
|
| US |
|
Cousins Properties Inc
NYSE:CUZ
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
A downturn in biotech and pharmaceutical funding could weaken demand for Alexandria’s specialized lab spaces, potentially increasing vacancy rates and pressuring rental growth in its core markets.
Heightened interest rates and rising construction costs may challenge the firm’s capital structure, forcing higher debt service requirements and limiting its ability to expand its development pipeline economically.
New competitive developments in prime life science hubs, including Boston and San Francisco, could saturate the market with lab space, undermining Alexandria’s pricing power and eroding its profit margins.
Demand for top-tier lab facilities remains robust, with the life sciences sector traditionally less sensitive to short-term economic swings, supporting Alexandria’s premium rents and long-term occupancy stability.
Alexandria’s strategic locations and deep relationships with marquee biotech and pharmaceutical tenants foster resilient cash flow, reflecting the company’s high-quality rent roll and stable credit profile.
Ongoing research and development growth in emerging fields like gene therapy and immuno-oncology will likely require more specialized labs, positioning Alexandria to capitalize on expanding infrastructure needs.
Revenue & Expenses Breakdown
Alexandria Real Estate Equities Inc
Balance Sheet Decomposition
Alexandria Real Estate Equities Inc
| Current Assets | 585.9m |
| Cash & Short-Term Investments | 579.5m |
| Receivables | 6.4m |
| Non-Current Assets | 36.8B |
| Long-Term Investments | 1.6B |
| PP&E | 32.7B |
| Intangibles | 235.3m |
| Other Non-Current Assets | 2.3B |
| Current Liabilities | 1.4B |
| Accounts Payable | 514.9m |
| Accrued Liabilities | 668.3m |
| Other Current Liabilities | 230.6m |
| Non-Current Liabilities | 19.3B |
| Long-Term Debt | 13.6B |
| Other Non-Current Liabilities | 5.7B |
Free Cash Flow Analysis
Alexandria Real Estate Equities Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Alexandria Real Estate Equities Inc
|
Revenue
|
3.2B
USD
|
|
Cost of Revenue
|
-930.5m
USD
|
|
Gross Profit
|
2.3B
USD
|
|
Operating Expenses
|
-1.5B
USD
|
|
Operating Income
|
777m
USD
|
|
Other Expenses
|
-1.2B
USD
|
|
Net Income
|
-421.1m
USD
|
ARE Profitability Score
Profitability Due Diligence
Alexandria Real Estate Equities Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
Alexandria Real Estate Equities Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
ARE Solvency Score
Solvency Due Diligence
Alexandria Real Estate Equities Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Score
Alexandria Real Estate Equities Inc's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ARE Price Targets Summary
Alexandria Real Estate Equities Inc
According to Wall Street analysts, the average 1-year price target for
ARE
is 65.75 USD
with a low forecast of 45.45 USD and a high forecast of 136.5 USD.
Dividends
Current shareholder yield for
ARE is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ARE
stock under the Base Case scenario is
68.33
USD.
Compared to the current market price of 48.76 USD,
Alexandria Real Estate Equities Inc
is
Undervalued by 29%.